Guangzhou Baiyunshan Pharmaceutical Holdings (00874): The asset-backed securities of the asset support special plan of the accounts receivable of Guangzhou Pharmaceuticals have obtained the letter of approval from the Shanghai Stock Exchange for listing and transfer.

Guangzhou Baiyunshan Pharmaceutical Holdings (00874) announced that on March 13, 2026, the company received a letter from Xingzheng Securities Asset Management Co., Ltd. ("Xingzheng Asset Management") forwarded by the Shanghai Stock Exchange ("SSE") regarding the listing and transfer of the asset-backed securities of Xingzheng Yuanrong-Guangzhou Medicine Receivables 5-9 Period Asset Support Special Plan ("No Objection Letter") (SSE [2026] No.830). The relevant details are as follows: The asset-backed securities of Xingzheng Yuanrong-Guangzhou Medicine Receivables 5-9 Period Asset Support Special Plan meet the listing and transfer conditions of the SSE, and the SSE has no objections to their listing and transfer. The asset-backed securities of Xingzheng Yuanrong-Guangzhou Medicine Receivables 5-9 Period Asset Support Special Plan are issued in stages, and all are non-renewable asset-backed securities with a total amount not exceeding 3 billion yuan. The initial issuance should be completed within 12 months from the date of issuance of the "No Objection Letter". The "No Objection Letter" is valid for 24 months from the date of issuance.